PANCRELIPASE: 724 Adverse Event Reports & Safety Profile
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
724
Total FAERS Reports
66 (9.1%)
Deaths Reported
281
Hospitalizations
724
As Primary/Secondary Suspect
32
Life-Threatening
13
Disabilities
Discontinued
Status
FDA Application: 020580 ·
First Report: 1993 · Latest Report: 20250908
What Are the Most Common PANCRELIPASE Side Effects?
#1 Most Reported
Diarrhoea
93 reports (12.8%)
#2 Most Reported
Drug ineffective
53 reports (7.3%)
#3 Most Reported
Abdominal pain upper
49 reports (6.8%)
All PANCRELIPASE Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Diarrhoea | 93 | 12.9% | 15 | 43 |
| Drug ineffective | 53 | 7.3% | 1 | 20 |
| Abdominal pain upper | 49 | 6.8% | 0 | 18 |
| Maternal exposure during pregnancy | 43 | 5.9% | 0 | 4 |
| Malaise | 41 | 5.7% | 1 | 20 |
| Nausea | 37 | 5.1% | 11 | 20 |
| Pain | 36 | 5.0% | 8 | 10 |
| Vomiting | 34 | 4.7% | 4 | 31 |
| Abdominal pain | 31 | 4.3% | 2 | 11 |
| Cough | 29 | 4.0% | 8 | 10 |
| Dyspnoea | 27 | 3.7% | 0 | 9 |
| Abdominal distension | 26 | 3.6% | 10 | 11 |
| Pyrexia | 26 | 3.6% | 1 | 22 |
| Asthenia | 25 | 3.5% | 11 | 16 |
| Blood pressure decreased | 25 | 3.5% | 7 | 21 |
| Fatigue | 25 | 3.5% | 8 | 16 |
| Foetal exposure during pregnancy | 25 | 3.5% | 4 | 6 |
| Condition aggravated | 24 | 3.3% | 1 | 7 |
| Decreased appetite | 23 | 3.2% | 3 | 16 |
| Inappropriate schedule of product administration | 23 | 3.2% | 6 | 17 |
Who Reports PANCRELIPASE Side Effects? Age & Gender Data
Gender: 50.4% female, 49.6% male. Average age: 52.0 years. Most reports from: US. View detailed demographics →
Is PANCRELIPASE Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2001 | 3 | 0 | 3 |
| 2003 | 2 | 0 | 2 |
| 2004 | 3 | 0 | 0 |
| 2007 | 2 | 0 | 2 |
| 2008 | 4 | 0 | 2 |
| 2009 | 2 | 0 | 1 |
| 2010 | 3 | 0 | 0 |
| 2011 | 4 | 0 | 3 |
| 2012 | 12 | 5 | 3 |
| 2013 | 39 | 11 | 13 |
| 2014 | 33 | 4 | 10 |
| 2015 | 30 | 3 | 8 |
| 2016 | 36 | 2 | 24 |
| 2017 | 29 | 3 | 15 |
| 2018 | 20 | 0 | 9 |
| 2019 | 15 | 2 | 11 |
| 2020 | 31 | 9 | 16 |
| 2021 | 25 | 0 | 9 |
| 2022 | 34 | 4 | 17 |
| 2023 | 20 | 1 | 7 |
| 2024 | 53 | 1 | 5 |
| 2025 | 5 | 0 | 1 |
What Is PANCRELIPASE Used For?
| Indication | Reports |
|---|---|
| Product used for unknown indication | 298 |
| Pancreatic failure | 64 |
| Cystic fibrosis | 60 |
| Pancreatic insufficiency | 42 |
| Pancreatitis chronic | 27 |
| Pancreatitis | 21 |
| Tonsillitis | 14 |
| Diarrhoea | 12 |
| Pancreatic enzyme abnormality | 8 |
| Suicide attempt | 7 |
PANCRELIPASE vs Alternatives: Which Is Safer?
PANCRELIPASE vs PANCRELIPASE AMYLASE\PANCRELIPASE LIPASE\PANCRELIPASE PROTEASE
PANCRELIPASE vs PANCURONIUM
PANCRELIPASE vs PANITUMUMAB
PANCRELIPASE vs PANOBINOSTAT
PANCRELIPASE vs PANTOPRAZOLE
PANCRELIPASE vs PANTOPRAZOLE ANHYDROUS
PANCRELIPASE vs PANTOTHENIC ACID
PANCRELIPASE vs PAPAVERINE
PANCRELIPASE vs PARACETAMOL
PANCRELIPASE vs PARATHYROID HORMONE
Official FDA Label for PANCRELIPASE
Official prescribing information from the FDA-approved drug label.